{"id":"https://genegraph.clinicalgenome.org/r/1fc4d234-70fd-45a1-84e6-58fac7971125v2.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *DNM1L* and encephalopathy due to mitochondrial and peroxisomal fission defect (EMPF), inherited in the autosomal dominant manner was evaluated using the ClinGen Clinical Validity Framework as of June, 2020 and updated as of April 2022. *DNM1L* encodes a member of the tripartite motif family. EMPF encompasses multiple phenotypes including lethal or non-lethal encephalopathy, delayed psychomotor development and hypotonia. Occasionally, cardiomyopathy and dystonia have also been  reported in patients. In some patients, it is accompanied by optic atrophy (PMID: 30850373,17460227), while in others, optic atrophy may be the only manifestation of disease (PMID: 28969390). Clinical evidence of a mitochondrial or peroxisomal effect may not always be seen in patients (PMID: 27145208). EMPF is also reported in the autosomal recessive mode of inheritance in a few families (PMID: 26825290, 27328748); these patients are noted, but not scored in this curation.\n\n*DNM1L* was first reported in relation to autosomal dominant EMPF in 2007. (Waterham et al, PMID: 17460227). At least 10 frameshift and missense variants have been reported in humans in the ClinVar database. Evidence supporting this gene-disease relationship includes case-level data, family data and experimental data.  \n   \nSummary of Case Level Data (12 points):\nVariants in this gene have been reported in at least 15 probands in 12 publications (PMID: 31587467, 17460227, 28969390, 27145208, 26604000, 30850373, 27301544, 26931468, 33718295, 30109270). Variants in this gene segregated with disease in at least 11 additional family members. More evidence is available in the literature, but the maximum score (12 points) for genetic evidence is reached. \n\nMost variants reported in the literature are de novo heterozygous missense variants that act in a dominant negative mechanism and interfere with protein assembly. A few patients with homozygous or compound heterozygous null variants have also been reported, in whom a loss of function mechanism is expected.    \n  \nSummary of experimental data (4 points):\nThis gene-disease association is supported by in vitro functional assays and animal models. *DNM1L* is shown to partially localize with the peroxisome and it is noted to be recruited to the peroxisome by PEX11; however, they do not interact physically (PMID: 12499366, 12618434) and mutant *DNM1L* expressed in heterologous cells show abnormal peroxisome morphology due to the fission defect, similar to that seen in patients (PMID: 12499366). Complete knock out of murine Dnm1l in mice is embryonic lethal and therefore conditional knock-out mice have been generated, which recapitulate features of EMPF in humans (PMID: 19752021, 28969390, 19578372).  \n  \nIn summary, *DNM1L* is definitively associated with encephalopathy due to mitochondrial and peroxisomal fission defect, inherited in the autosomal dominant inheritance pattern. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.\n\nLumping & Splitting: OMIM entities: AD/AR Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 (MIM# 614388); AD Optic atrophy 5 (MIM# 610708). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism AND phenotypic variability. Optic atrophy has been reported as an isolated and accompanying feature to EMPF and the molecular mechanism is reported to dominant negative in both instances (PMID: 30850373,17460227, 28969390). Autosomal recessive EMPF is reported due to a loss of function mechanism with clinical features similar to AD EMPF ( PMID: 27328748, 26825290). The AD EMPF and AD optic atrophy entities have been lumped into one entity, encephalopathy due to mitochondrial and peroxisomal fission defect (MONDO:0013726). Though the AR EMPF entity has not been lumped, these patients are noted in this curation.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1fc4d234-70fd-45a1-84e6-58fac7971125","GCISnapshot":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:otherTextChange"},{"id":"cg:summaryChange"},{"id":"cg:newEvidence"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10049","date":"2022-04-15T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10049","date":"2022-04-21T21:08:05.936Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83e10378-059a-48be-a65d-b74657616707_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28969390","rdfs:label":"Gerber_Family II","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/83e10378-059a-48be-a65d-b74657616707","type":"Family","rdfs:label":"Gerber_Family II","member":{"id":"https://genegraph.clinicalgenome.org/r/25718889-b9cc-4700-8e6f-d6b1548a8629","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28969390","rdfs:label":"Family II-III:3","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c8a4120-8bcc-4308-8fc2-1fd75fabfe01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.5A>C (p.Glu2Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384359086"}},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0000648","previousTesting":true,"previousTestingDescription":"Screening of OPA1, OPA3 and WFS1 exonic sequences and of the three main mitochondrial mutations responsible for the Leber hereditary optic neuropathy was negative. Metabolic work-up, neurological examination, 3 T cerebral MRI with spectroscopy, audiogram and auditory evoked potentials recordings and cardiac echo-sonography in two individual in the family aged 75 and 46 years, respectively, detected no sign consistent with mitochondrial dysfunction.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6cac214e-80c8-42ce-9f82-d8d897490315_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28969390","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c8a4120-8bcc-4308-8fc2-1fd75fabfe01"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"All affected individuals from the family were described with a phentoype similar to that of OPA1-related Dominant Optic Atrophy","phenotypePositiveAllelePositive":8,"phenotypes":"obo:HP_0000648","proband":{"id":"https://genegraph.clinicalgenome.org/r/25718889-b9cc-4700-8e6f-d6b1548a8629"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/18aec258-e321-466d-b028-684605b2e3a3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28969390","rdfs:label":"Gerber_Family I","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/18aec258-e321-466d-b028-684605b2e3a3","type":"Family","rdfs:label":"Gerber_Family I","member":{"id":"https://genegraph.clinicalgenome.org/r/9ec40924-90c5-4926-a8d9-a390388a0c85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28969390","rdfs:label":"Family I-III:5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":49,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4c8a4120-8bcc-4308-8fc2-1fd75fabfe01"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Color vision defect since 45yo. Reading difficulty since 47yo. Light sensitivity decreased in central visual field. Several errors without defined axis. Retinal nerve fiber layer thickness was decreased in all sectors predominating in temporal and inferior quadrants. Decreased amplitudes and delayed responses in pattern VEPs. Moderate hearing loss with flat audiometric curve (30 dB)","phenotypes":["obo:HP_0000365","obo:HP_0012511","obo:HP_0000551","obo:HP_0000649","obo:HP_0007663"],"previousTesting":true,"previousTestingDescription":"Routine screening of the OPA1, OPA3 and WFS1 exonic sequences and of the three main mitochondrial mutations responsible for the Leber hereditary optic neuropathy was performed.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/788ee2aa-69d5-4d1e-a8a0-b26969be0ddd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28969390","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c8a4120-8bcc-4308-8fc2-1fd75fabfe01"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000648","obo:HP_0012511"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9ec40924-90c5-4926-a8d9-a390388a0c85"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/788ee2aa-69d5-4d1e-a8a0-b26969be0ddd","type":"EvidenceLine","dc:description":"The proband and 4 others younger individuals (10y or older) in the family were affected by nonsyndromic optic atrophy. WES identified an inherited missense variant, Glu2Ala. The proband is scored reduced points in the absence of in-vitro functional studies, but with some functional evidence in patient cells. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/788ee2aa-69d5-4d1e-a8a0-b26969be0ddd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/788ee2aa-69d5-4d1e-a8a0-b26969be0ddd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutant protein in patient fibroblasts (III:6) was expressed at the normal level and was thought to act as a dominant negative allele and affect homopolymer activity. IF on mutant cells showed that DNM1L formed aggregates localized both in the cytoplasm and on the mitochondrial network, but not associated with mitochondrial constriction sites, while DNM1L aggregates were more abundant on the mitochondrial network of control cells. Assessment of mitochondria revealed highly elongated network with a 2.5-fold decrease in the number of mitochondrial extremities in mutated cells. No difference between mutated and control cells were noted with respect to the structure of the peroxisomal network. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/e48b1de1-8970-4131-b98b-64d50fdf785f","type":"EvidenceLine","dc:description":"The proband was heterozygous for the missense variant, Gly350Arg. The variant was determined to be de novo as it was absent in the father but the mother was found to have mild mosaicism (6-8%). Functional studies in Drosophila support the dominant negative mechanism. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e48b1de1-8970-4131-b98b-64d50fdf785f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26931468","allele":{"id":"https://genegraph.clinicalgenome.org/r/edda5cad-1131-4192-a96f-caa1fb5e1ef7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.1048G>A (p.Gly350Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586279"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e48b1de1-8970-4131-b98b-64d50fdf785f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies were performed in Drosophila. Drosophila Drp1 mutants are lethal. Transgenic drosophila created with human DNM1L with and without the variants were used to rescue the lethal phenotype caused by Drp1 mutant. While the WT rescued, hDNM1L-G350R did not rescue lethality. In addition, hDNM1L-G350R was associated with increased peroxisomal size and decreased numbers of total peroxisomes. A remarkable alteration in morphology, distribution and trafficking of muscle mitochondria was also observed","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/16a67159-2092-48be-b225-a08b4313dc27","type":"EvidenceLine","dc:description":"The proband was heterozygous for a de novo missense variant in the GTPase Effector domain (GED) of DNM1L, maternity and paternity not confirmed. Global metabolomic profiling on the patient did not reveal any analytes altered in PBDs. Functional evidence supports dominant negative mechanism. Increased points are awarded.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16a67159-2092-48be-b225-a08b4313dc27_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30850373","allele":{"id":"https://genegraph.clinicalgenome.org/r/003cf54d-49fe-4b62-9c76-0609ed0be6be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.2072A>G (p.Tyr691Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/619028"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/16a67159-2092-48be-b225-a08b4313dc27_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies carried out in D. melanogaster showed that expression of this variant in DNM1L null mutant flies did not rescue lethality although some escapers were observed. In transgenic flies expressing the variant, larger peroxisomal size and perinuclear distribution of peroxisomes was seen in salivary glands. These flies also displayed a network of mitochondria near the muscle perinuclear region with a scarcity of mitochondria in muscle fibers as compared with wild-type. Expression of a mutant lacking the entire GED resulted in partial rescue of lethality, indicating the mechanism to be dominant negative rather than haploinsufficiency/LOF. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d270cd43-d1b7-40bf-8a0d-6073be0381e9","type":"EvidenceLine","dc:description":"The proband was heterozygous for a de novo missense variant, Leu406Ser in the middle domain of the protein. Functional analysis was not performed; however the variant was expected to act in a dominant negative manner and affect the assembly of the DNM1L protein. Immunocytochemistry on patient fibroblasts showed defects of fission in peroxisomes and mitochondria. In light of functional evidence from patient cells and proband having a de novo variant, 1 pt is awarded. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d270cd43-d1b7-40bf-8a0d-6073be0381e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27301544","allele":{"id":"https://genegraph.clinicalgenome.org/r/55e1452a-4783-4064-bee1-e708f67ef180","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.32731372T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384357696"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/17be7902-f261-429b-a402-51bde0e9551f","type":"EvidenceLine","dc:description":"The proband had a de novo heterozygous missense variant, Ala395Asp, with confirmation of maternity and paternity. Functional evidence is available from patient cells and in-vitro studies performed in PMID: 20696759 and PMID: 26931468. The evidence is scored increased points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17be7902-f261-429b-a402-51bde0e9551f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460227","allele":{"id":"https://genegraph.clinicalgenome.org/r/f0ee733f-2dd1-4ae3-b629-92646873207a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.1184C>A (p.Ala395Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117911"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/17be7902-f261-429b-a402-51bde0e9551f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies in PMID: 20696759 show that the variant causes markedly elongated mitochondria, which are a consequence of decreased fission, likely due to higher order DNM1L complexes not forming or being unstable at mitochondria. Patient skin fibroblast analyzed by IF showed fewer peroxisomes, varying n size and arranged in rows. Mitochondria were elongated. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/afda03f0-8521-47bc-923b-ebc20ba048b3","type":"EvidenceLine","dc:description":"The proband and his similarly affected brother were compound heterozygous for a frameshift variant, Glu116Lysfs*6, inherited from the father, and a missense variant, Ser36Gly. inherited from the mother.  Immunofluorescence studies on patient fibroblasts showed cytoplasmic distribution of the DNM1L protein. A defect in the mitochondrial fission machinery was shown that could be rescued by expressing the wild-type DNM1L. In patient fibroblasts, peroxisomes were larger and less uniformly distributed in the cytoplasm and appeared elongated. Morphometric analysis showed reduced shape factor and increased area in the patient's cells compared to controls. The evidence is noted for information but not scored any points as the disorder shows an autosomal recessive inheritance pattern in the family. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afda03f0-8521-47bc-923b-ebc20ba048b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27328748","allele":{"id":"https://genegraph.clinicalgenome.org/r/33e4ae31-42b0-4e48-a8c8-39a60b386ba2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.106A>G (p.Ser36Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586278"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/afda03f0-8521-47bc-923b-ebc20ba048b3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Complementation studies in yeast with the Ser36Gly variant revealed that a large number of cells expressing the missense variant showed fragmented mitochondria, similar to cells expressing the null allele. The missense variant is shown to be hypomorphic, acting through a a loss of function mechanism. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e58d6980-7717-4d62-8c8c-2f18b74a3498","type":"EvidenceLine","dc:description":"This variant, Arg403Cys, has also been noted in the de novo state in two unrelated probands in PMID: 30109270. The evidence is scored maximum points for a missense variant with functional evidence seen in multiple unrelated individuals.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e58d6980-7717-4d62-8c8c-2f18b74a3498_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27145208","allele":{"id":"https://genegraph.clinicalgenome.org/r/40a96a4f-d52b-4cc9-9140-29c85438b277","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.1207C>T (p.Arg403Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA324758"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e58d6980-7717-4d62-8c8c-2f18b74a3498_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Authors expressed the variant in mouse embryonic fibroblasts (MEFs) that were Dnm1l-null and show only partial rescue of mitochondrial fission, which is absent in the null cells and have highly elongated and interconnected mitochondria. When the variant was expressed in wild-type MEFs with endogenous Dnm1l, variant interfered with fission activity and resulted in mitochondrial elongation compared to control cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a680fe5e-c08c-4355-92e6-4f6ed9ea47c8","type":"EvidenceLine","dc:description":"The proband was found to carry a de novov heterozygous DNM1L missense variant, Gly363Asp. Maternity and paternity were not confirmed. Patient fibroblasts showed hyperfused mitochondrial phenotype; however, bioenergetics studies revealed no difference between patient and control fibroblasts. Note, Gly362Ser has also been reported in a patient with chronic neurological disorder, postnatal microcephaly, developmental delay, decreased respiratory chain complex IV activity, and pain insensitivity (PMID: 26992161) and a patient with encephalopathy, epilepsy, and global developmental delay (PMID: 31475481). The proband is scored 0.5 points; however, the score is increased to 1 pt for multiple occurrences. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a680fe5e-c08c-4355-92e6-4f6ed9ea47c8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26604000","allele":{"id":"https://genegraph.clinicalgenome.org/r/10781d87-9e98-478b-ba33-b81d2e1cdd9a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.1085G>A (p.Gly362Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586275"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a680fe5e-c08c-4355-92e6-4f6ed9ea47c8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies evidence from PMID: 20696759 suggests that this variant, occurring in the middle domain, may have the same effect as others in the domain on the assembly of DNM1L protein. In the absence of direct evidence, reduced points are awarded. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e5d4d4c8-1ab3-4a6c-87a1-52b15723584a","type":"EvidenceLine","dc:description":"The proband and his similarly affected brother were compound heterozygous for a frameshift variant, Glu116Lysfs*6, inherited from the father, and a missense variant, Ser36Gly. inherited from the mother.  Immunofluorescence studies on patient fibroblasts showed cytoplasmic distribution of the DNM1L protein. A defect in the mitochondrial fission machinery was shown that could be rescued by expressing the wild-type DNM1L. In patient fibroblasts, peroxisomes were larger and less uniformly distributed in the cytoplasm and appeared elongated. Morphometric analysis showed reduced shape factor and increased area in the patient's cells compared to controls. The evidence is noted for information but not scored any points as the disorder shows an autosomal recessive inheritance pattern in the family.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5d4d4c8-1ab3-4a6c-87a1-52b15723584a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27328748","allele":{"id":"https://genegraph.clinicalgenome.org/r/64ff995e-25e1-4bfb-aafe-d46bc32b27d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.346_347del (p.Glu116LysfsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6507318"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e5d4d4c8-1ab3-4a6c-87a1-52b15723584a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The frameshift variant is expected to cause NMD and this was evidenced by finding strongly reduced mRNA from the LOF allele in patient cDNA. The Glu116LysfsTer16 is reported in gnomAD v2.1.1 at a frequency of 0.00008720 (3/34402 Latino alleles) with no homozygotes.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/63f62870-25b4-4f32-b8ab-6de4d098a5bc","type":"EvidenceLine","dc:description":"The proband and 2 other individuals in the family were heterozygous for the missense variant, Ala192Glu. Minimal points are awarded in the absence of functional evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63f62870-25b4-4f32-b8ab-6de4d098a5bc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28969390","allele":{"id":"https://genegraph.clinicalgenome.org/r/02ee35a1-730f-4ec6-90a3-55974767c22e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.575C>A (p.Ala192Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384367791"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/21f873a3-66b0-4d3b-bbc1-a44b7068e073","type":"EvidenceLine","dc:description":"The proband and her similarly affected brotehr (both died in infancy) were compound heterozygous for two frameshift variants each inherited from a parent. The evidence is noted for information but not scored any points as the variants are reported in autosomal recessive inheritance. Note, Glu116LysfsTer6 is noted in the paper as NM_001278464.1:c.385_386del (p.Glu129Lys*6)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21f873a3-66b0-4d3b-bbc1-a44b7068e073_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26825290","allele":{"id":"https://genegraph.clinicalgenome.org/r/64ff995e-25e1-4bfb-aafe-d46bc32b27d1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/21f873a3-66b0-4d3b-bbc1-a44b7068e073_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"IF of the sural nerve revealed absent DNM1L protein in both patients compared with an age-matched control. EM performed on the right hippocampus showed multiple giant mitochondria within hippocampal neurons that contained elongated cristae arranged parallel to each other. No peroxisomal defects are noted. The Glu116LysfsTer16 is reported in gnomAD v2.1.1 at a frequency of 0.00008720 (3/34402 Latino alleles) with no homozygotes. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0dec6dbf-293e-42aa-b358-2cfefd36d11f","type":"EvidenceLine","dc:description":"The proband was heterozygous for the missense variant in the middle domain of DNM1L, that was determined to be de novo. Functional studies on patient fibroblasts showed reduced ATP production and oxygen consumption by 30% and 40%, respectively. Mitochondria showed elongated morphology by TEM. he proband did not show impaired peroxisome structure, morphology or function, and had normal VLCFA plasma profile.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0dec6dbf-293e-42aa-b358-2cfefd36d11f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26992161","allele":{"id":"https://genegraph.clinicalgenome.org/r/eb07feb6-63a9-494c-96b1-edad91b44820","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.1084G>A (p.Gly362Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586276"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0dec6dbf-293e-42aa-b358-2cfefd36d11f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Introduction of the mutated gene in human foreskin fibroblasts showed significantly altered mitochondrial morphology. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ac7ea164-ba2b-4d34-a547-1a30bdf08422","type":"EvidenceLine","dc:description":"The proband was heterozygous for the de novo missense variant, Gly149Arg, with confirmation of maternity and paternity. In the absence of functional evidence, the proband is scored for the de novo variant.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac7ea164-ba2b-4d34-a547-1a30bdf08422_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33718295","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b9dfae5-d8f6-4b20-b96c-48f156ab9be5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.445G>A (p.Gly149Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384367012"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/66070c8b-5bab-4e57-a00f-48c9517c92fe","type":"EvidenceLine","dc:description":"The proband and her similarly affected brotehr (both died in infancy) were compound heterozygous for two frameshift variants each inherited from a parent. The evidence is noted for information but not scored any points as the variants are reported in autosomal recessive inheritance. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66070c8b-5bab-4e57-a00f-48c9517c92fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26825290","allele":{"id":"https://genegraph.clinicalgenome.org/r/f565850c-4741-4902-94af-fdd510dd7519","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012062.5(DNM1L):c.251-1532dup","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586277"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/66070c8b-5bab-4e57-a00f-48c9517c92fe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"IF of the sural nerve revealed absent DNM1L protein in both patients compared with an age-matched control. EM performed on the right hippocampus showed multiple giant mitochondria within hippocampal neurons that contained elongated cristae arranged parallel to each other. No peroxisomal defects are noted. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9048300c-85e9-45a3-9815-82bedea259f1","type":"EvidenceLine","dc:description":"The proband had a de novo heterozygous variant in DNM1L, with confirmation of maternity and paternity (trio WES). Autopsy showed features consistent with described DNM1L mitochondrial disorder with severe mitochondrial encephalopathy. Skeletal muscle showed myopathic features and cardiac myocytes had enlarged mitochondria, separation of myofibrils, and interstitial fibrosis. Functional evidence is absent; however de novo variant with confirmed maternity and paternity is scored 1 point.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9048300c-85e9-45a3-9815-82bedea259f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31587467","allele":{"id":"https://genegraph.clinicalgenome.org/r/01fe7d22-b554-4264-9567-e639d3b5bfa6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.32731383G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384358359"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6cac214e-80c8-42ce-9f82-d8d897490315","type":"EvidenceLine","dc:description":"The proband and 7 others in the family were heterozygous for the missense change, Glu2Ala. No points are scored as the variant has been previously awarded points for proband in Family 1-III:5","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cac214e-80c8-42ce-9f82-d8d897490315_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1847b095-d28e-4c2b-8b96-7aadc945f904","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca96b7c5-5cbd-44cc-9940-e8dca3927e43","type":"Finding","dc:description":"Patients with DNM1L mutations reported in the literature show varying phenotypes and levels of severity. Some patients show peroxisomal morphological changes in fibroblasts, predominantly seen as elongated peroxisomes. The evidence shows that the missense variant, Lys38Ala, also results in a a similar peroxisomal phenotype.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12499366","rdfs:label":"Koch_DNM1L Peroxisome fission","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/320f4ab3-19c3-458e-9e81-0f380cbfebbd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d40b36a-6f77-4afd-bbed-8d3cbe8972e8","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f86d1aa3-f131-45a1-87f4-8d57135140fb","type":"Finding","dc:description":"Overexpression of the wild-type protein resulted in cells displaying peroxisomal and mitochondrial phenotype similar to control fibroblasts.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460227","rdfs:label":"Waterham_Rescue in patient cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3393762f-a960-45c8-87e9-efd864502598","type":"EvidenceLine","dc:description":"The score is slightly increased for evidence on both complete and conditional knock out models.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/076ca359-fe14-4471-9fe8-f85f6f818a5b","type":"Finding","dc:description":"DNM1L heterozygous mice were viable, fertile and normal in size. Homozygous mice were not seen in the litter indicating that homozygous null DNM1L is embryonic lethal. These null embryos lookes smaller than age-matched littermates that were WT-DNM1L or DNM1L-/+, indicating developmental delay.\n\nMouse embryonic fibroblasts from DNM1L-/- mice showed highly connected, elongated mitochondrial tubules that could be rescued by reexpression of DNM1L. IF using antibodies to Pex14 and EM of peroxisomal catalase staining showed relatively round peroxisomes in WT but elongated ones in DNM1L-/-. Using the conditional KO mouse, the authors showed that the cerebellum of mutant mice had completely smooth surfaces, and itssize was decreased to âˆ¼60% of control cerebella, while in control mice, cerebellum was round, but the lobule formations were relatively shallow fissures. Gerber et al (PMID: 28969390) show in these heterozygous knock-out mice that Dnm1l variation caused mitochondrial elongation in retinal ganglion cells without axonal degeneration and no optic nerve defects in 3mo mice.\n\nIshihara et al, (PMID: 19578372) also generated Dnm1l- knock-out mice, which resulted in embryonic lethality. Reduced development of heart and liver, thinned neural tube cell layer were observed in dead embryos, along with enlarged/extended mitochondria and swollen peroxisomes. Neural-specific Dnm1L deletion also led to death shortly after birth.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19752021","rdfs:label":"Wakabayashi_Complete and Conditonal KO Mouse models","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":4267,"specifiedBy":"GeneValidityCriteria7","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/W2G2XVqksus","type":"GeneValidityProposition","disease":"obo:MONDO_0054865","gene":"hgnc:2973","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_320f4ab3-19c3-458e-9e81-0f380cbfebbd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}